INTCO Medical 2025 Annual Report: Steady Growth, Global Expansion, and AI-Driven Innovation

INTCO Medical has released its 2025 Annual Report, highlighting steady revenue growth, strong global manufacturing capacity, and continued investment in innovation and sustainability.

INTCO Medical 2025 Annual Report: Steady Growth, Global Expansion, and AI-Driven Innovation

Solid Financial Performance Amid Market Challenges

In 2025, INTCO Medical achieved total revenue of RMB 9.926 billion, representing a year-on-year increase of 4.23%. While net profit attributable to shareholders declined to RMB 1.011 billion due to external market fluctuations, the company maintained strong financial resilience.

Operating cash flow reached RMB 1.885 billion, marking a significant increase of 74.69% year-on-year, reflecting improved operational efficiency. Meanwhile, net assets attributable to shareholders grew steadily to RMB 18.254 billion, up 4.88%.

Expanding Global Manufacturing Scale

INTCO continues to strengthen its position as a large-scale medical consumables manufacturer through ongoing capacity expansion and industrial optimization.

The company’s disposable glove capacity has reached 103 billion units annually, including:

• 70 billion nitrile gloves
• 33 billion PVC gloves

This large-scale production capability ensures stable supply, cost competitiveness, and strong support for global bulk demand.

At the same time, INTCO is continuously improving its diversified product system, covering medical consumables, rehabilitation medical equipment, and physical therapy products, forming a comprehensive healthcare ecosystem.

Integrated Global Production and Supply Network

INTCO operates more than 10 R&D and manufacturing bases worldwide, forming a robust global production system. Key facilities include glove production bases in Zibo, Qingzhou, Huaibei, Anqing, and Jiangxi, as well as specialized manufacturing sites for rehabilitation products and medical consumables.

In addition, the company has established global marketing centers in Shanghai, Hong Kong, the United States, Germany, Canada, Japan, and Malaysia. This integrated network enables efficient global delivery and faster response to customer needs.

Innovation and AI Driving Operational Efficiency

Innovation remains a core growth engine for INTCO Medical. In 2025, the company invested RMB 404 million in R&D, accounting for 4.07% of total revenue, and accumulated 298 patents across the group and its subsidiaries.

INTCO Medical continues to develop new materials and product formulations, launching innovative products such as:

• Syntex™ synthetic latex gloves
• ShinyGuard™ food-grade nitrile gloves
• PE protection kits and personal care products

At the same time, the company is actively embracing artificial intelligence by building internal data centers and deploying localized AI models, enhancing efficiency, product quality, and decision-making capabilities.

Global Market Expansion and Brand Growth

INTCO Medical’s global presence continues to expand, with products sold in over 150 countries and regions. The company serves more than 15,000 clients worldwide, supported by a global marketing team of over 500 professionals.

In 2025, INTCO participated in 27 international exhibitions and further strengthened its omnichannel strategy, covering B2B platforms, e-commerce marketplaces, and social media channels.

The company’s brand value has reached RMB 19.618 billion, with continued recognition among China’s Top 500 Brands.

ESG Commitment and Sustainable Development

Sustainability remains a key pillar of INTCO’s long-term strategy. The company continues to advance green energy projects, including clean energy initiatives in Anhui, while optimizing its energy structure.

By the end of 2025, cumulative charitable donations reached RMB 76.86 million. INTCO has also received multiple ESG recognitions, including EcoVadis certification and inclusion in major ESG rankings.

Future Outlook: Building a Resilient Global Healthcare Platform

Looking ahead, INTCO Medical will continue to focus on globalization, innovation, and manufacturing efficiency. By strengthening its industrial capabilities and customer connections, the company aims to build a more resilient and higher-value global healthcare platform.